EMEA-000183-PIP01-08-M05

Key facts

Invented name
Eliquis
Active substance
Apixaban
Therapeutic area
Cardiovascular diseases
Decision number
P/0196/2017
PIP number
EMEA-000183-PIP01-08-M05
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral liquid
Condition(s) / indication(s)
  • Prevention of arterial thromboembolism
  • Prevention of venous thromboembolism
Route(s) of administration
Oral use
Contact for public enquiries
Bristol-Myers Squibb / Pfizer EEIG
United Kingdom
Tel. +44 1895523740
E-mail: medical.information@bms.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating